https://doi.org/
Poster
NOT PEER REVIEWED
Download
metrics
VIEWS
72
 
downloads
8
CITE
How to cite this poster:
Lavranos T, Beaumont D, Gasic J et al. Evaluation of the anti-cancer effects of the tumor selective vascular disruption agent BNC105 in preclinical renal cancer models. F1000Posters 2011, 2:114 (poster)

Evaluation of the anti-cancer effects of the tumor selective vascular disruption agent BNC105 in preclinical renal cancer models

TC Lavranos1, TC Lavranos2, DM Beaumont, J Gasic, AF Leske, G Kremmidiotis
Published 28 Feb 2011
Author Affiliations
  • Metrics
  • 72 Views
  • 8 Downloads
Browse by related subjects
Published 28 Feb 2011

Evaluation of the anti-cancer effects of the tumor selective vascular disruption agent BNC105 in preclinical renal cancer models

[version 1; not peer reviewed]

TC Lavranos1, TC Lavranos2, DM Beaumont, J Gasic, AF Leske, G Kremmidiotis
Author Affiliations
1 Neurofit SAS, France
2 Bionomics Ltd, Australia
Presented at
23rd Lorne Cancer Conference 2011
Abstract
Competing Interests

TC Lavranos and Gabriel Kremmidiotis are both paid employees of Bionomics Ltd and hold stock in the company; all the other authors are also paid employees of Bionomics Ltd.

Comments
0 Comments
 
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.